| ATC Class | Antimicrobial | Total cost/1,000 inhabitants ($) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BC | AB | SK | MB | ON | QC | NB | NS | PEI | NL | |||
| Roman numerals I to III indicate the ranking of antimicrobials based on importance in human medicine as outlined by the Veterinary Drugs Directorate. ATC = Anatomical Therapeutic Chemical. NPD = No prescriptions dispensed. NC = Not classified. |
||||||||||||
| I | Amoxicillin and enzyme inhibitor | Combinations of penicillins, including ß-lactamase inhibitors (J01CR) | 1.88 | 2.14 | 1.63 | 1.99 | 1.56 | 2.36 | 2.14 | 2.42 | 4.26 | 4.98 |
| Cefixime | Third-generation cephalosporins (J01DD) | 0.46 | 0.43 | 0.14 | 0.31 | 0.53 | 0.38 | 0.34 | 0.56 | 1.98 | 0.97 | |
| Ofloxacin, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin | Fluoroquinolones (J01MA) | 9.64 | 10.78 | 7.98 | 10.73 | 11.75 | 11.78 | 11.53 | 10.83 | 14.34 | 21.63 | |
| Vancomycin | Glycopeptides (J01XA) | 0.52 | 0.27 | 0.10 | 0.21 | 0.32 | 1.10 | 0.18 | 0.30 | 0.19 | 0.41 | |
| Metronidazole | Imidazole (J01XD) | 0.68 | 0.82 | 0.74 | 0.81 | 1.01 | 0.61 | 0.83 | 0.93 | 0.69 | 1.18 | |
| Linezolid | Linezolid (J01XX) | 0.41 | 0.20 | 0.21 | 0.04 | 0.24 | 0.55 | 0.05 | 0.31 | 0.05 | 0.53 | |
| II | Ampicillin, amoxicillin, pivampicillin | Penicillins with extended spectrum (J01CA) | 7.15 | 8.33 | 11.58 | 9.98 | 9.79 | 5.31 | 8.68 | 8.72 | 8.29 | 15.07 |
| Penicillin G, penicillin V | ß-lactamase sensitive penicillins (J01CE) | 1.20 | 1.31 | 0.93 | 1.50 | 0.99 | 1.60 | 1.41 | 1.24 | 1.14 | 1.36 | |
| Cloxacillin | ß-lactamase resistant penicillins (J01CF) | 0.50 | 0.45 | 1.02 | 1.32 | 0.47 | 0.38 | 0.42 | 0.59 | 0.53 | 1.06 | |
| Cephalexin, cefadroxil | First-generation cephalosporins (J01DB) | 4.16 | 3.99 | 5.83 | 4.25 | 3.56 | 1.84 | 4.07 | 4.12 | 3.75 | 5.52 | |
| Cefaclor, cefprozil, cefuroxime axetil | Second-generation cephalosporins (J01DC) | 1.73 | 2.60 | 1.36 | 2.08 | 4.03 | 3.82 | 5.55 | 4.48 | 1.67 | 4.42 | |
| Sulfamethoxazole and trimethoprim, sulfadiazine and trimethoprim | Combinations of sulfonamides and trimethoprim, including derivatives (J01EE) | 1.21 | 1.23 | 1.81 | 1.63 | 1.05 | 0.63 | 1.43 | 1.77 | 1.69 | 1.86 | |
| Azithromycin, clarithromycin, erythromycin | Macrolides (J01FA) | 12.39 | 15.23 | 12.72 | 14.25 | 17.76 | 14.43 | 17.75 | 16.12 | 18.37 | 23.58 | |
| Clindamycin | Lincosamides (J01FF) | 2.29 | 2.74 | 3.21 | 1.78 | 2.19 | 1.84 | 2.47 | 2.34 | 1.83 | 1.92 | |
| Tobramycin | Aminoglycosides (J01GB) | 0.58 | 0.52 | 1.17 | 0.90 | 0.62 | 1.00 | 1.98 | 0.03 | NPD | 0.04 | |
| Nalidixic acid | Other quinolones, excluding fluoroquinolones (J01MB) | NPD | NPD | NPD | NPD | < 0.01 | NPD | NPD | NPD | NPD | NPD | |
| Erythromycin-sulfisoxazole | Sulfonamide combinations, excluding trimethoprim (J01RA) | NPD | NPD | NPD | NPD | NPD | < 0.01 | NPD | NPD | NPD | NPD | |
| Fusidic acid | Steroid antibacterials (J01XC) | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | 0.01 | < 0.01 | < 0.01 | 0.10 | NPD | |
| III | Doxycycline, minocycline, tetracycline | Tetracyclines (J01AA) | 4.21 | 5.28 | 4.29 | 3.75 | 3.96 | 3.14 | 3.32 | 4.81 | 4.17 | 4.58 |
| Trimethoprim | Trimethoprim and derivatives (J01EA) | 0.06 | 0.06 | 0.18 | 0.02 | 0.10 | 0.11 | 0.09 | 0.05 | 0.02 | 0.15 | |
| Sulfadiazine, sulfamethoxazole | Intermediate-acting sulfonamides (J01EC) | NPD | < 0.01 | NPD | NPD | < 0.01 | NPD | NPD | NPD | NPD | NPD | |
| Nitrofurantoin | Nitrofuran derivatives (J01XE) | 1.75 | 1.46 | 2.64 | 1.07 | 2.14 | 0.74 | 1.75 | 2.42 | 1.51 | 1.29 | |
| Fosfomycin | Fosfomycin (J01XX) | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | 0.01 | NPD | < 0.01 | |
| NC | Methenamine | Methenamine (J01XX) | 0.02 | 0.01 | 0.01 | < 0.01 | 0.01 | 0.03 | 0.02 | < 0.01 | NPD | 0.01 |
| Total (J01) | 50.88 | 57.85 | 57.57 | 56.62 | 62.08 | 51.66 | 64.01 | 62.04 | 64.57 | 90.56 | ||